Teva Pharmaceutical Industries Limited Share Price TEL AVIV STOCK EXCHANGE
Stocks
TEVA
IL0006290147
Pharmaceuticals
OTC Markets Traded|
Delayed
TEL AVIV STOCK EXCHANGE
06:51:18 10/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 11,150.00 ILa | +0.18% |
|
+1.36% | +10.51% |
| 04/09 | S&P Global Ratings Upgrades Teva Pharmaceutical to 'BBB-' | MT |
| 04/09 | Vaxcyte Names New Medical and Legal Chiefs Ahead of Key Phase 3 Data | MT |
| Market Cap | 4.29TCr 0 3.7TCr 3.48TCr 3.17TCr 5.93TCr 4,08600Cr 5.96TCr 41TCr 16TCr 2,08200Cr 16TCr 16TCr 6,59500Cr | P/E 2026 * |
52.8x | P/E 2027 * | 21.8x |
|---|---|---|---|---|---|
| Enterprise Value | 5.48TCr 0 4.72TCr 4.44TCr 4.05TCr 7.58TCr 5,21900Cr 7.61TCr 53TCr 20TCr 2,65900Cr 21TCr 20TCr 8,42300Cr | EV / Sales 2026 * |
3.3x | EV / Sales 2027 * | 2.98x |
| Free-Float |
88.59% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
TEL AVIV STOCK EXCHANGE
| TEVA | Delayed | |
OTC Markets
| TEVJF | Delayed |
Last Transcript : Teva Pharmaceutical Industries Limited
| 1 day | +0.18% | ||
| 1 week | +1.36% | ||
| Current month | +4.11% | ||
| 1 month | +4.69% | ||
| 3 months | +10.18% | ||
| 6 months | +14.14% | ||
| Current year | +10.51% |
| 1 week | 10,680 |  | 11,260 |
| 1 month | 10,650 | | 11,530 |
| Current year | 8,860 | | 11,530 |
| 1 year | 6,082 | | 11,530 |
| 3 years | 3,250 | | 11,530 |
| 5 years | 2,383 | | 11,530 |
| 10 years | 2,175 | | 19,900 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Francis
CEO | Chief Executive Officer | 57 | 01/01/2023 |
Eli Kalif
DFI | Director of Finance/CFO | 53 | 22/12/2019 |
Matthew Shields
COO | Chief Operating Officer | 52 | 03/06/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Amir Elstein
BRD | Director/Board Member | 69 | 01/01/2009 |
Sol Barer
CHM | Chairman | 78 | 06/02/2017 |
Rosemary Crane
BRD | Director/Board Member | 65 | 01/09/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.18% | +1.36% | - | - | 4.29TCr | |
| +0.52% | -3.09% | +49.77% | +91.69% | 1,00200Cr | |
| +1.04% | -2.95% | +50.93% | +66.34% | 64TCr | |
| +0.66% | -4.13% | +19.24% | +68.37% | 44TCr | |
| -0.65% | -2.95% | +30.03% | +36.27% | 34TCr | |
| +0.96% | -13.75% | +12.43% | +28.25% | 26TCr | |
| +0.48% | -3.64% | -1.76% | +11.45% | 24TCr | |
| -0.20% | -11.65% | +39.75% | +50.82% | 21TCr | |
| -0.61% | -4.41% | -17.91% | -57.85% | 20TCr | |
| +0.15% | -2.65% | +25.82% | +91.64% | 18TCr | |
| Average | +0.28% | -5.00% | +23.14% | +43.00% | 39.22TCr | |
| Weighted average by Cap. | +0.42% | -4.24% | +32.25% | +57.61% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.66TCr 0 1.43TCr 1.35TCr 1.23TCr 2.29TCr 1,58000Cr 2.3TCr 16TCr 6.16TCr 80TCr 6.23TCr 6.1TCr 2,55000Cr | 1.73TCr 0 1.49TCr 1.4TCr 1.28TCr 2.39TCr 1,64800Cr 2.4TCr 17TCr 6.43TCr 84TCr 6.5TCr 6.36TCr 2,66000Cr |
| Net income | 127.48Cr 0 109.7Cr 103.29Cr 94Cr 176.09Cr 12TCr 176.79Cr 1.22TCr 473.14Cr 6.18TCr 478.69Cr 468.29Cr 20TCr | 243.3Cr 0 209.36Cr 197.13Cr 179.62Cr 336.08Cr 23TCr 337.41Cr 2.34TCr 903Cr 12TCr 913.61Cr 893.75Cr 37TCr |
| Net Debt | 1.19TCr 0 1.02TCr 964.39Cr 878.72Cr 1.64TCr 1,13300Cr 1.65TCr 11TCr 4.42TCr 58TCr 4.47TCr 4.37TCr 1,82800Cr | 865.23Cr 0 744.53Cr 701.04Cr 638.76Cr 1.2TCr 82TCr 1.2TCr 8.31TCr 3.21TCr 42TCr 3.25TCr 3.18TCr 1,32900Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/26/10 | ILA 11,150.00 | +0.18% | 5,47,307 |
| 09/26/09 | ILA 11,130.00 | +1.92% | 10,48,196 |
| 08/26/08 | ILA 10,920.00 | +0.09% | 10,86,826 |
| 07/26/07 | ILA 10,910.00 | -0.46% | 4,99,288 |
| 04/26/04 | ILA 10,960.00 | -0.36% | 4,73,654 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TEVA Stock
- TEVA Stock
Select your edition
All financial news and data tailored to specific country editions
